111 related articles for article (PubMed ID: 8968395)
21. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.
Chandler WL; Levy WC; Stratton JR
Circulation; 1995 Nov; 92(10):2984-94. PubMed ID: 7586269
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.
McWilliam N; Robbie L; Booth N; Bennett B
Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Ye B; Chou YL; Karanjawala R; Lee W; Lu SF; Shaw KJ; Jones S; Lentz D; Liang A; Tseng JL; Wu Q; Zhao Z
Bioorg Med Chem Lett; 2004 Feb; 14(3):761-5. PubMed ID: 14741285
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
25. Highly potent fibrinolytic serine protease from Streptomyces.
Uesugi Y; Usuki H; Iwabuchi M; Hatanaka T
Enzyme Microb Technol; 2011 Jan; 48(1):7-12. PubMed ID: 22112764
[TBL] [Abstract][Full Text] [Related]
26. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
Wodziński MA; Bardhan KD; Reilly JT; Cooper P; Preston FE
Gut; 1993 Oct; 34(10):1310-4. PubMed ID: 8244093
[TBL] [Abstract][Full Text] [Related]
27. Tanshinones increase fibrinolysis through inhibition of plasminogen activator inhibitor-1.
Xiao YH; Yang LF; Feng XC; Yang H; Ma TH
CNS Neurosci Ther; 2012 May; 18(5):436-8. PubMed ID: 22533728
[No Abstract] [Full Text] [Related]
28. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
29. Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.
Sier CF; Vloedgraven HJ; Ganesh S; Griffioen G; Quax PH; Verheijen JH; Dooijewaard G; Welvaart K; van de Velde CJ; Lamers CB
Gastroenterology; 1994 Nov; 107(5):1449-56. PubMed ID: 7926508
[TBL] [Abstract][Full Text] [Related]
30. Myosin as cofactor and substrate in fibrinolysis.
Machovich R; Ajtai K; Kolev K; Owen WG
FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
[TBL] [Abstract][Full Text] [Related]
31. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activator inhibitor-1 in kidney pathology (Review).
Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
[TBL] [Abstract][Full Text] [Related]
33. Vitronectin Regulates the Fibrinolytic System during the Repair of Cerebral Cortex in Stab-Wounded Mice.
Hashimoto K; Ikeda N; Nakashima M; Ikeshima-Kataoka H; Miyamoto Y
J Neurotrauma; 2017 Nov; 34(22):3183-3191. PubMed ID: 28683586
[TBL] [Abstract][Full Text] [Related]
34. The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.
Sidelmann J; Jespersen J; Kluft C; Gram J
Clin Chim Acta; 1997 May; 261(1):43-56. PubMed ID: 9187504
[TBL] [Abstract][Full Text] [Related]
35. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
37. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
38. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
39. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
40. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
